Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 1 clinical trials
Study Evaluating the Safety and Efficacy of Semaglutide and the Fixed-Dose Combination of Cilofexor and Firsocostat Alone and in Combination in Participants With Compensated Cirrhosis (F4) Due to Nonalcoholic Steatohepatitis (NASH)

The primary objective of this study is to evaluate whether the combination of semaglutide (SEMA) with the fixed-dose combination (FDC) of cilofexor/firsocostat (CILO/FIR) causes fibrosis

  • 0 views
  • 20 Sep, 2021
  • 2 locations